Zobrazeno 71 - 80
of 91
pro vyhledávání: '"G. Caleb Alexander"'
Autor:
Matthew Daubresse, Lisa Vera, G. Caleb Alexander, Rachel Kornfield, Yoonsang Kim, Sherry Emery, Yaru Shi
Publikováno v:
Nicotinetobacco research : official journal of the Society for Research on Nicotine and Tobacco. 18(5)
INTRODUCTION: Televised direct-to-consumer advertising (DTCA) for prescription drugs is controversial, especially for tobacco cessation products such as varenicline, given safety concerns that arose only after its market approval. We aim to quantify
Autor:
Peter Wickersham, Yang Qiu, Kevin Bowen, G. Caleb Alexander, Catherine I. Starner, Patrick P. Gleason
Publikováno v:
Health affairs (Project Hope). 33(10)
Expenditures for specialty drugs account for more than 25 percent of total US drug spending and have been increasing at more than 13 percent annually. We examined insurers' role in maintaining the affordability and accessibility of specialty drugs wh
Autor:
G. Caleb Alexander, Kevin M. Fain
Because of internet searches, advice from friends, and pharmaceutical advertising, especially direct-to-consumer advertising, patients are increasingly activated to request medications during a physician encounter.To estimate the effect of patient re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e280ca616eb9913e0f6315ffe1bfc4ab
https://europepmc.org/articles/PMC4031617/
https://europepmc.org/articles/PMC4031617/
Autor:
G. Caleb Alexander
Publikováno v:
Journal of general internal medicine. 29(1)
The study by Faerber and Kreling1 adds to a growing literature about direct-to-consumer advertising (DTCA), a unique form of drug advertising prohibited in most of the world. They found that of television ads airing from 2008 to 2010, 33 % were objec
Publikováno v:
BMC Health Services Research, Vol 12, Iss 1, p 435 (2012)
BMC Health Services Research
BMC Health Services Research
Background While extensive evidence suggests that the economic recession has had far reaching effects on many economic sectors, little is known regarding its impact on prescription drug utilization. The purpose of this study is to describe the associ
Publikováno v:
JAMA. 308(18)
PRESCRIPTION DRUGS, INCLUDING AMPHETAMINES, OPIoids, and benzodiazepines, provide therapeutic value to millions of Americans. At the same time, there are increasing concerns about the skyrocketing rates of prescription abuse and overdose deaths. The
Publikováno v:
Medical care. 50(11)
Background Off-label prescribing, or the use of a medicine for non-Food and Drug Administration (FDA)-approved indications, is especially common for psychotropic therapies and often lacks scientific support. We quantified the association between 4 co
Publikováno v:
PLoS
PLoS ONE, Vol 8, Iss 3, p e55504 (2013)
PLoS ONE
PLoS ONE, Vol 8, Iss 3, p e55504 (2013)
PLoS ONE
Background: Pharmaceutical firms heavily promote their products and may have changed marketing strategies in response to reductions in new product approvals, restrictions on some forms of promotion, and the expanding role of biologic therapies. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ad60e952938182ad5c6e34ecc9d0560
http://hdl.handle.net/1721.1/78572
http://hdl.handle.net/1721.1/78572
Publikováno v:
Journal of general internal medicine. 26(6)
Since safety concerns regarding prescription drugs are often discovered only after a medicine has been approved and released on the market, FDA regulatory advisories serve as an important means of communicating risk information to providers and to th
The Part D drug benefit represents the single largest change to Medicare in its 40-year history. Because of the size of the program—the program enrolls over 25 million seniors and is expected to cost over U.S.$700 billion in its first 10 years of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e436851fb7511b30192380b284b3973f
https://europepmc.org/articles/PMC2813441/
https://europepmc.org/articles/PMC2813441/